What's Happening?
Paul Bennett, the chief executive of the Royal Pharmaceutical Society (RPS), is set to step down from his position in April 2026. This decision comes as the Society transitions into a royal college, a move supported by 71.1% of its members in a March 2025 vote. Bennett, who has been in the role since 2017, will continue to lead the organization through this transition period. Karen Baxter, currently the deputy chief executive, will take over as interim chief executive from April 2026. The transition involves registering the RPS as a charity and restructuring its leadership team, including the recruitment of new roles such as a chair of trustees, director of finance and technology, director of pharmacy, and director of education.
AD
Why It's Important?
The transition of the Royal Pharmaceutical Society into a royal college marks a significant shift in its organizational structure and strategic direction. This change is expected to enhance its ability to deliver professional leadership within the pharmacy sector. The restructuring aims to ensure the new Royal College of Pharmacy has the necessary skills and capabilities to thrive, with a focus on sustainable financial and technological foundations. The move to become a charity and the establishment of a publishing subsidiary are strategic steps to bolster its future operations. This transition could impact the pharmacy profession by providing a more robust framework for advocacy, education, and professional development.
What's Next?
As the transition progresses, the RPS will focus on recruiting for key leadership roles to support its new structure. The organization will work to ensure a smooth transition and establish a strong foundation for the Royal College of Pharmacy. The leadership team will aim to build upon the momentum established under Bennett's guidance, with Baxter committed to working closely with the current team to achieve these goals. The new royal college is expected to launch in April 2026, with plans to implement an ambitious strategy to support the pharmacy profession.
Beyond the Headlines
The transition to a royal college could have broader implications for the pharmacy sector, potentially influencing how pharmacy professionals engage with their governing body. The move may also affect the Society's ability to advocate for policy changes and provide educational resources. The restructuring could lead to a more collaborative and strategic approach to leadership within the pharmacy community, fostering innovation and growth.
